A. Two sample subsets defined by the AF-gene set in Fig. 1a (p = 0.003)
|
Group A, n = 21
|
NR
|
NR
|
NR
|
NR
|
Reference group
|
Group B, n = 39
|
0.76 (0.63–0.91)
|
0.60 (0.45–0.81)
|
0.54 (0.38–0.78)
|
0.54 (0.38–0.78)
|
NE
|
B. Two sample subsets defined by the OVCA-gene set in Fig. 1b (p < 0.001)
|
Group A, n = 18
|
NR
|
0.97 (0.91–1.00)
|
0.97 (0.91–1.00)
|
0.97 (0.91–1.00)
|
Reference group
|
Group B, n = 42
|
0.53 (0.34–0.81)
|
0.28 (0.12–0.67)
|
0.19 (0.06–0.61)
|
0.19 (0.06–0.61)
|
38.7 (5.0–296.9)
|
C. Two sample subsets defined by the RCC-gene set in Fig. 1c (p = 0.003)
|
Group A, n = 35
|
0.94 (0.86–1.00)
|
0.90 (0.80–1.00)
|
0.90 (0.80–1.00)
|
0.90 (0.80–1.00)
|
Reference group
|
Group B, n = 25
|
0.71 (0.55–0.92)
|
0.56 (0.38–0.81)
|
0.46 (0.27–0.78)
|
0.46 (0.27–0.78)
|
5.4 (1.5–19.3)
|
D. Two sample subsets defined by the combined gene set in Fig. 1d (p = 0.029)
|
Group A, n = 14
|
NR
|
NR
|
NR
|
NR
|
Reference Group
|
Group B, n = 46
|
0.80 (0.69–0.93)
|
0.66 (0.52–0.84)
|
0.59 (0.43–0.82)
|
0.59 (0.43–0.82)
|
NE
|
E. Three sample subsets defined by the combined gene set in Fig. 1e (p < 0.001)
|
Group A, n = 14
|
NR
|
NR
|
NR
|
NR
|
Reference Group
|
Group B1, n = 17
|
NR
|
NR
|
NR
|
NR
|
NE
|
Group B2, n = 29
|
0.68 (0.53–0.88)
|
0.47 (0.29–0.74)
|
0.39 (0.22–0.70)
|
0.39 (0.22–0.70)
|
NE
|
F. Two sample subsets defined by the combined gene set in Fig. 1F (p < 0.001).
|
Good group, n = 32
|
NR
|
NR
|
NR
|
NR
|
Reference Group
|
Poor group, n = 28
|
0.67 (0.52–0.87)
|
0.48 (0.32–0.74)
|
0.40 (0.23–0.70)
|
0.40 (0.23–0.70)
|
NE
|